The term cardiomyopathy refers to a variety of conditions in which the heart muscle becomes weakened or abnormally thickened, affecting its ability to pump blood effectively. Cardiomyopathies can be either inherited or acquired, with genetic mutations often playing a significant role in conditions like hypertrophic cardiomyopathy. As these diseases progress, they may lead to arrhythmias or heart failure, making early intervention crucial. Management strategies typically involve a combination of medications, lifestyle adjustments, and monitoring to prevent complications. In some cases, patients may require devices like pacemakers or even a heart transplant. With greater awareness and advancements in treatment, cardiomyopathies are becoming more manageable, offering hope for affected individuals.
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States, United States
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, Tianjin University, China
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title :
Federico Benetti, Benetti Foundation, Argentina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation